White House health report omits Trump’s finasteride use

A recent medical report for President Donald Trump has prompted questions about White House health disclosures after it omitted a medication that had been listed in his previous official records. The report, summarizing a physical examination conducted on May 26, did not include finasteride, a drug commonly used to treat male-pattern hair loss and sold under the brand name Propecia.

The omission was noted because the medication had appeared in health summaries released during Trump’s first term. When asked about the discrepancy, a White House spokesperson stated that the current report reflects all medications deemed clinically relevant to disclose at this time. The spokesperson added that no additional undisclosed conditions or procedures materially affecting his health status were omitted.

The three-page report, authored by Dr. Sean Barbabella, described the 79-year-old president as being in excellent health. It stated that Trump demonstrates strong cardiac, pulmonary, neurological, and overall physical function and is fully fit to carry out all duties of the Commander-in-Chief. The report listed other medications, including cholesterol drugs and a low-dose aspirin regimen for...